IGF-2 has been shown to regulate cellular contractility and proliferation in DC [12] and recently it was suggested that CTGF, a TGF-β target gene and a potent activator of the AKT signaling pathway is implicated in the pathogenesis of fibrotic diseases including DC [11, 21]. The gene discussed is TGFB1; the disease is dyskeratosis congenita.